Does a relationship of HLA B alleles with course of hepatitis C virus infection in children and youth and efficacy of its treatment exist?

被引:0
|
作者
Los-Rycharska, Ewa [1 ]
Czerwionka-Szaflarska, Mieczyslawa [1 ]
Szaflarska-Poplawska, Anna [2 ]
机构
[1] Uniwersytetu Mikolaja Kopernika, Katedra & Klin Pediat Alergol & Gastroenterol, Coll Med Ludwika Rydygiera Bydgoszczy, Toruniu, Poland
[2] Uniwersytetu Mikolaja Kopernika, Zaklad Endoskopii & Badan Czynnosciowych Przewodu, Coll Med Ludwika Rydygiera Bydgoszczy, Toruniu, Poland
来源
PRZEGLAD GASTROENTEROLOGICZNY | 2011年 / 6卷 / 03期
关键词
HLA B; HCV; children; youth; antiviral therapy; CLASS-I; ASSOCIATION; POPULATION; PERSISTENCE; PROGRESSION; CLEARANCE; MHC;
D O I
10.5114/pg.2011.22801
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Introduction: The course of HCV infection and prognosis for its treatment depend not only on virus factors (e.g. genotype) but also of host lying, as genetic conditions. A particular role is attributed to major histocompatibility complex genes. Aim: To estimate the relationship of HLA B alleles with alanine transferase activity (ALT) as expression of the course of infection and attempt to estimate the relationship of the alleles with efficiency of antiviral treatment. Material and methods: The study included 61 patients with persistent viral hepatitis type C, aged 5-18 years, 51 treated (42 with interferon and ribavirin) and 10 not treated. Among treated patients, 31 did not respond and in 20 a sustained virological response was obtained. In all patients HLA typing was performed (HLA PCR-SSP method, low and next high resolutions). Frequency of particular HLA B alleles was compared among groups of patients (with correct and increased ALT activity, responders and non-responders for antiviral treatment). Results: In the analysis of the influence of HLA B alleles on ALT activity in the course of HCV infection a significant dependence was not ascertained. Analysing early and sustained response to antiviral treatment significant dependence was not ascertained either. Conclusions: The results do not confirm associations between HLA B alleles and ALT activity in the course of HCV infection nor between these alleles and efficiency of antivirat treatment. Due to the fact that multiplicity of HLA B alleles exists, considering some indispensable insignificant differences, it is necessary to perform a study on a larger group of patients.
引用
收藏
页码:160 / 169
页数:10
相关论文
共 50 条
  • [31] Efficacy and safety of sofosbuvir/ledipasvir for the treatment of patients with hepatitis C virus re-infection after liver transplantation
    Ciesek, S.
    Proske, V.
    Otto, B.
    Pischke, S.
    Costa, R.
    Luethgehetmann, M.
    Polywka, S.
    Klempnauer, J.
    Nashan, B.
    Manns, M. P.
    von Hahn, T.
    Lohse, A. W.
    Wedemeyer, H.
    Mix, H.
    Sterneck, M.
    TRANSPLANT INFECTIOUS DISEASE, 2016, 18 (03) : 326 - 332
  • [32] Influence of selected HLA tissue compatibility antigens on the course and efficacy of viral hepatitis C treatment - actual knowledge position
    Los-Rycharska, E.
    Szaflarska-Poplawska, A.
    ADVANCES IN MEDICAL SCIENCES, 2009, 54 (01): : 14 - 19
  • [33] Safety and efficacy of Sofosbuvir and Velpatasvir in children with active hepatitis C virus infection undergoing haploidentical transplantation
    Jaiswal, Sarita Rani
    Bhakuni, Prakash
    Soni, Mayank
    Gupta, Mahesh
    Thatai, Atul
    Chakrabarti, Suparno
    TRANSPLANT INFECTIOUS DISEASE, 2021, 23 (02)
  • [34] Frequency and Associated Risk Factors of Hepatitis B Virus and Hepatitis C Virus Infections in Children at a Hepatitis Prevention and Treatment Clinic in Lahore, Pakistan
    Seerat, Iqtadar
    Mushtaq, Humaira
    Rafiq, Memona
    Nadir, Abdul
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (05)
  • [35] Non-invasive screening of HLA-DPA1 and HLA-DPB1 alleles for persistent hepatitis B virus infection: Susceptibility for vertical transmission and toward a personalized approach for vaccination and treatment
    Lau, Kin-Chong
    Lam, Ching-Wan
    Law, Chun-Yiu
    Lai, Sik-To
    Tsang, Tak-Yin
    Siu, Carol Wai-Kwan
    To, Wing-Kin
    Leung, Ka-Fai
    Mak, Chloe Miu
    Poon, Wing-Tat
    Chan, Paul Kay-Sheung
    Chan, Yan-Wo
    CLINICA CHIMICA ACTA, 2011, 412 (11-12) : 952 - 957
  • [36] Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment
    Bissig, Karl-Dimiter
    Wieland, Stefan F.
    Tran, Phu
    Isogawa, Masanori
    Le, Tam T.
    Chisari, Francis V.
    Verma, Inder M.
    JOURNAL OF CLINICAL INVESTIGATION, 2010, 120 (03) : 924 - 930
  • [37] Liver histology of treatment-naive children with chronic hepatitis B virus infection in Shanghai China
    Hu, Yao
    Wu, Xia
    Ye, Yingzi
    Ye, Lijing
    Han, Shuzhen
    Wang, Xiaohong
    Yu, Hui
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 123 : 112 - 118
  • [38] Clinical and virological characteristics of coexistent hepatitis B surface antigen and antibody in treatment-naive children with chronic hepatitis B virus infection
    Xu, Yi
    Li, Shuangjie
    Ouyang, Wenxian
    Yao, Zhenzhen
    Lai, Xin
    Gu, Yingping
    Yang, Meng
    Ye, Ling
    Li, Sisi
    Peng, Songxu
    FRONTIERS IN PUBLIC HEALTH, 2024, 12
  • [39] Sofosbuvir/ledipasvir fixed-dose combination for treatment of chronic hepatitis C virus infection in children
    Rizza, S. A.
    Nehra, V.
    Temesgen, Z.
    DRUGS OF TODAY, 2017, 53 (08) : 447 - 451